Tested Applications
| Positive WB detected in | Human liver |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
65011-1-Ig targets CPS1 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgG |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Recombinant Protein Predict reactive species |
| Full Name | carbamoyl-phosphate synthetase 1, mitochondrial |
| Calculated Molecular Weight | 165 kDa |
| GenBank Accession Number | BC020695 |
| Gene Symbol | CPS1 |
| Gene ID (NCBI) | 1373 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P31327 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at 2-8°C. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The CPS1 Monoclonal antibody (Cat# 65011-1-Ig) has 2 total citations. These appear in Cell Death Dis (2021), studying natural compound-based autophagy modulators and chemotherapeutic mechanisms, and Biomater Res (2024), investigating genetically modified hepatocytes for bioartificial liver systems targeting bilirubin and ammonia metabolism. Both citations used the antibody for Western blot in human samples, spanning research fields of cell death/autophagy and regenerative medicine/bioartificial organ engineering.
| Species | Application | Title |
|---|---|---|
Cell Death Dis High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol. | ||
Biomater Res Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System |
